Autor: |
Cors-Cepeda, Ximena, Ganguly, Amvrine, James, Monique C. |
Předmět: |
|
Zdroj: |
Industrial Psychiatry Journal; 2024 Supplement, Vol. 33 Issue 1, pS278-S279, 2p |
Abstrakt: |
This article from the Industrial Psychiatry Journal discusses a case of a 47-year-old male patient with metastatic rectal cancer who developed extrapyramidal syndrome (EPS) subtypes while on prochlorperazine. The patient's symptoms included dystonia, akathisia, and parkinsonism, which improved with the administration of Benztropine IV and Lorazepam. The case highlights the importance of recognizing and managing EPS in patients receiving dopamine-receptor-blocking agents to ensure optimal patient care. The article emphasizes the need for healthcare professionals to promptly address adverse effects and consider individual risk factors to minimize complications. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|